Centessa Pharmaceuticals plc Quarterly Depreciation, Depletion and Amortization in USD from Q4 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Centessa Pharmaceuticals plc quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q4 2020 to Q1 2024.
  • Centessa Pharmaceuticals plc Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $240K, a 170% increase year-over-year.
  • Centessa Pharmaceuticals plc annual Depreciation, Depletion and Amortization for 2023 was $810K, a 518% increase from 2022.
  • Centessa Pharmaceuticals plc annual Depreciation, Depletion and Amortization for 2022 was $131K, a 285% increase from 2021.
  • Centessa Pharmaceuticals plc annual Depreciation, Depletion and Amortization for 2021 was $34K.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $240K +$151K +170% Mar 31, 2024 10-Q 2024-05-13
Q1 2023 $89K +$61K +218% Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $28K +$26K +1300% Mar 31, 2022 10-Q 2023-05-12
Q1 2021 $2K Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $0 Jan 29, 2021 10-K 2023-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.